AVIR
Atea Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.83
+0.17%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-81.0%
Return on equity
-71.2%
Return on assets
-89.7%
Return on invested capital
0.00x
Asset turnover
-$152.1M
Cash from operations
$2.74
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026